ARCHIVES

Biopsy System Effective In Removing Benign Breast Masses, Study Finds

This article is from The Cancer Letter archive.

Vol. 27 No. 5 | May 28, 2004

Download PDF Visit The Full Archive

Related Articles

FDA Faces Severe Regulatory, Scientific Needs, Report Finds.

February 1, 2008

Cytogen Corp.’s Imaging Agent ProstaScint Added to NCCN Prostate Cancer Guidelines.

March 31, 2000

Simmons Cancer Center at UT Southwestern Wins NCI Comprehensive Designation and $7.5 Million.

September 10, 2010

In Brief: Treatment Reorganization Plan Due In November, Rauscher Says; Panel To Review Clinical Activities

June 27, 1975

No Justification Provided: AAUP Demands Reinstatement of Faculty Denied Tenure Renewal at MD Anderson

May 16, 2014

Advisors Recommend Listing Estrogen As Carcinogen.

January 12, 2001